Hypertension in pregnancy: diagnosis and management

blood tests such as rising creatinine or liver transaminases or falling platelet count, or failure of fetal growth or abnormal doppler findings. Recommendations for research As part of the 2019 update, the guideline committee made 6 research recommendations on the management of pregnancy with chronic hypertension, pre-eclampsia, fetal monitoring, the use of antihypertensives in breastfeeding and advice and follow-up. A research recommendation from the 2010 guideline which was superseded by these new research recommendations was deleted, and 3 research recommendations where research was now underway or had been completed were also deleted. Key recommendations for research 1 Management of chronic hypertension in pregnancy In women who need treatment for chronic hypertension in pregnancy, what is the effectiveness and safety of antihypertensive agents (compared in head-to-head trials) in improving maternal and perinatal outcomes? [2019] For a short explanation of why the committee made this recommendation for research, see the rationale and impact section on pre-eclampsia. Full details of the evidence and the committee's discussion are in evidence review A: interventions for chronic hypertension. 2 Management of hypertension in pregnancy In women who need treatment for hypertension in pregnancy, what are the adverse neonatal outcomes associated with maternal use of beta blockers
